The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan-effectiveness, pitfalls and promises

Ann Transl Med. 2022 May;10(9):501. doi: 10.21037/atm-22-621.

Authors

Emanuela Guerra^{1

2}, Saverio Alberti^{1

3}

Affiliations

¹ Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), University "G. D'Annunzio", Chieti, Italy.
² Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.
³ Unit of Medical Genetics, Department of Biomedical Sciences, University of Messina, Messina, Italy.

No abstract available

Publication types

Editorial
Comment